ASH Annual Meeting

Na Shen^1*, Xiaojian Zhu^2*, Shu Zhou^1*, Yong You^1*, Zhaodong Zhong, PhD^1*, Xiaoying Zhu^1*, Qing Li, PhD^3*, Ping Zou^1* and Yicheng Zhang⁴

¹Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
³Department of Hematology, Wuhan No.1 Hospital, Wuhan, China
⁴Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Kibeom Jang, PhD^1* and Neil P. Shah, MD, PhD^2,3

¹UCSF, San Francisco, CA
²Department of Medicine/Hematology-Oncology, UCSF School of Medicine, San Francisco, CA
³Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA

Margaret Nieborowska-Skorska^1*, Paulina Podszywalow-Bartnicka^2*, Silvia Maifrede^1*, Bac Viet Le^1*, Monika Toma^3*, Peter Valent⁴, Tomasz Sliwinski^3*, Wayne Childers^5*, Katarzyna Piwocka^2*, Alexei Tulin^6* and Tomasz Skorski, MD, PhD¹

¹Temple University School of Medicine, Philadelphia, PA
²Nencki Institute of Experimental Biology, Warsaw, Poland
³University of Lodz, Lodz, Poland
⁴Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
⁵Temple University School of Pharmacy, Phialdelphia, PA
⁶University of North Dacota, Grand Forks, ND

Daniel Thomson, PhD, BSc^1,2*, Hezrin Shahrin, PhD^2,3*, Paul Wang, PhD^3,4*, Carol Wadham, PhD^2,3*, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA⁵, Andreas Schreiber, PhD^3,4* and Susan Branford, PhD^2,3

¹Centre for Cancer Biology, Adelaide, SA, Australia
²Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
³Centre for Cancer Biology, Adelaide, Australia
⁴ACRF Cancer Genomic Facility, Adelaide, Australia
⁵Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia

Constance Baer, PhD¹, Wolfgang Kern, MD¹, Torsten Haferlach, MD² and Claudia Haferlach, MD¹

¹MLL Munich Leukemia Laboratory, Munich, Germany
²MLL Munchner Leukamie Labor Gmbh, Munchen, Germany

Kyle Spinler, BS, DPhil¹, Tannishtha Reya, PhD², Jeevisha Bajaj, PhD³, Takahiro Ito^4*, Bryan Zimdahl, PhD^5*, Armin Ahmadi, BS^6*, Claire Koechlein^7*, Nikki Lytle^8*, Hyog Young Kwon, PhD^6*, Ferdous Anower-E-Khuda, PhD^6*, Marcie Kritzik^6*, Jan Karlseder^9*, Pyong Woo Park, PhD^10* and Jeffrey Esko, PhD^6*

¹Pharmacology, University of California San Diego, San Diego, CA
²University of California, San Diego, La Jolla, CA
³Pharmacology, University of California, San Diego, La Jolla, CA
⁴University of Georgia, Athens, GA
⁵University of California San Diego, Emeryville, CA
⁶University of California San Diego, La Jolla
⁷University of California San Diego, La Jolla, CA
⁸University of California San DIego, La Jolla
⁹The Salk Institute For Biological Studies, San Diego, CA
¹⁰Boston Children's Hospital, Boston

Mieszko Lachota^*, Marta Siernicka, MSc^*, Zofia Pilch, PhD^*, Agnieszka Graczyk-Jarzynka, PhD^* and Magdalena Winiarska, PhD^*

Department of Immunology, Medical University of Warsaw, Warsaw, Poland